HUENENBERG, Switzerland--(BUSINESS WIRE)--The Alcon Independent Director Committee (the “IDC”) notes the conditional election of five designees to the Board of Directors of Alcon, Inc. (“Alcon”) proposed by Novartis AG (“Novartis”). The conditional election took place at an extraordinary general meeting (“EGM”) of the Alcon shareholders, held yesterday in Zug, Switzerland.
